# Infusion Yield Optimization

*/Opportunities/Infusion_Yield_Optimization*

## Opportunity Overview

**Wedge**: The initial wedge targets independent rheumatology and gastroenterology infusion centers administering high-cost biologics like Infliximab. These centers run simpler regimens than oncology but still suffer from high vial costs and waste, providing an immediate and highly visible financial return. Expansion proceeds into community oncology centers with complex multi-drug regimens, followed by enterprise hospital outpatient infusion networks.
**Timing**: Current optimization models process combinatorial scheduling algorithms in real-time, matching dynamic patient arrival states with strict USP compounding time limits without manual pharmacy calculation.
**Why This I C P**: Independent community oncology and specialty infusion centers face immense margin pressure from changing reimbursement rules and absorb the direct financial sting of drug waste immediately.
**Size Of Prize**: There are approximately 3,800 hospital-based and independent oncology and infusion centers in the US. Charging $50,000 annually per center for yield optimization software yields an addressable market of $190M.
**Gap Narrative**: Outpatient infusion centers waste expensive biologic and oncology drug vials because static scheduling prevents vial sharing across patients. Current pharmacy management systems track inventory but lack the ability to dynamically shuffle patient appointments and drug compounding times to maximize yield from single-use vials.
**Defensibility**: Defensibility compounds through workflow lock-in as the system takes over the daily pharmacy compounding schedule. The data asset grows stronger over time by capturing historical patient no-show rates, actual chair times, and exact drug clearance times, allowing the scheduling model to achieve optimization yields that generic EHR modules cannot replicate.
**Why This Thesis**: A Service-as-Software approach bypasses the rigid, legacy IT constraints of standard Electronic Health Records. The service ingests the daily appointment feed and returns an optimized compounding sequence directly to the pharmacy tech without requiring a heavy interface integration.

## Opportunity Linked Thesis

**Thesis**: [Software](/Theses/Software)

## Opportunity Linked I C P

**Icp**: [Infusion Center](/CompanyTypes/Infusion_Center)

## Opportunity Market Sizing

_Illustrative — target and order-of-magnitude estimate figures, not an achieved track record (this Thing is concept-stage)._

**S A M**: ~$150M - $200M targeting mid-to-large independent oncology and rheumatology infusion centers
**S O M**: ~$10M - $25M
**T A M**: ~12,000 US outpatient infusion sites × ~$40k/yr ≈ ~$480M
**Growth Rate**: ~12-15%/yr, driven by the migration of specialty drug administration to outpatient sites and rising biological drug costs
**Paid Comparable Spend**: ~$60k - $120k/yr in manual scheduling FTE labor, basic EHR add-on fees, and absorbed costs from spoiled biologic inventory

## Opportunity Incumbents

- [Epic Willow](/Products/Epic_Willow) — Tool
- [Omnicell IVX](/Products/Omnicell_IVX) — Tool
- [Baxter DoseEdge](/Products/Baxter_DoseEdge) — Tool
- [Manual Dose Tracking](/Products/Manual_Dose_Tracking) — Spreadsheet
- [Outsourced 503B Facilities](/Products/Outsourced_503B_Facilities) — Service
- [BD Cato Workflow](/Products/BD_Cato_Workflow) — Tool

## Opportunity Win Conditions

**Kill Thresholds**:
- Recommendation acceptance rate < 30% after 14 days of usage
- Zero biologic vials saved within the first 30 days of deployment
- EHR integration blocks deployment for > 45 days
- CAC > $15k per independent clinic site during the initial 90 days
**Leading Metrics**:
- Percentage of patient batching recommendations accepted by schedulers
- Days to first completely saved biologic vial
- Daily active usage by compounding pharmacists
- Weekly volume of unutilized drug waste tracked in milliliters
**What Proves Right**: Oncology and rheumatology centers reduce spoiled biologic inventory by at least 15% within 30 days of deployment. Clinic schedulers actively use the platform to batch patients requiring the same vial sizes, proving workflow integration. Facilities absorb the $3,000 monthly fee directly from their operational waste reduction budgets rather than requiring specialized capital expenditure approval.
**What Proves Wrong**: Clinical staff reject the scheduling recommendations because patient availability strictly overrides drug batching efficiency. Pharmacists bypass the yield optimization workflows during high-volume periods to avoid compounding delays. The actual recovered cost from saved biologic vials falls below the monthly software subscription, rendering the ROI negative.

## Opportunity Build Profile

**Hardest Part**: Mapping unpredictable clinical realities like patient late arrivals and variable pharmacy preparation times into deterministic constraint solvers without causing chair bottlenecks. This requires a robust stochastic optimization engine that handles minute-by-minute clinical deviations.
**Min Viable Scope**: Deliver a static next-day scheduler strictly for single-chair infusion slots on predictable biologic regimens to maximize daily chair utilization. Deliberately exclude real-time dynamic rescheduling, multi-drug sequential chemotherapy, and nurse staffing optimization.
**Cold Start Problem**: The system lacks empirical data on actual treatment durations versus scheduled blocks for specific drug regimens across different patient profiles. Break this by executing a read-only historical EMR integration with a single high-volume specialty clinic to map baseline duration variances before deploying live schedules.
**Time To First Value**: 3 weeks of historical EMR data ingestion and baseline mapping to deliver the first optimized chair schedule template
**Data Moat Available**: true
**Technical Difficulty**: High

## Neighborhood

### Where the gap lives

- [Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism](/ChapterCondition/Diseases_of_the_blood_and_blood-forming_organs_and_certain_disorders_involving_the_immune_mechanism) — latent gap · ChapterCondition

### Applies thesis

- [Infusion Center](/CompanyTypes/Infusion_Center) — applies thesis · CompanyTypes

### Incumbent in

- [BD Cato Workflow](/Products/BD_Cato_Workflow) — incumbent in · Products
- [Baxter DoseEdge](/Products/Baxter_DoseEdge) — incumbent in · Products
- [Epic Willow](/Products/Epic_Willow) — incumbent in · Products
- [Manual Dose Tracking](/Products/Manual_Dose_Tracking) — incumbent in · Products
- [Omnicell IVX](/Products/Omnicell_IVX) — incumbent in · Products
- [Outsourced 503B Facilities](/Products/Outsourced_503B_Facilities) — incumbent in · Products

### Embodies

- [Software](/Theses/Software) — embodies · Theses

### Similar Opportunities

- [Perishable Inventory Router](/Occupations/Healthcare_Practitioners_and_Technical_Occupations/Opportunities/Perishable_Inventory_Router) — similar · Opportunities
- [Autonomous Infusion Coordinator](/Opportunities/Autonomous_Infusion_Coordinator) — similar · Opportunities
- [Ward Supply Predictor](/Opportunities/Ward_Supply_Predictor) — similar · Opportunities
- [Predictive Staff Allocation](/Opportunities/Predictive_Staff_Allocation) — similar · Opportunities
- [Preference Card Automation](/Opportunities/Preference_Card_Automation) — similar · Opportunities
- [Algorithmic Block Management](/Opportunities/Algorithmic_Block_Management) — similar · Opportunities
- [Intelligent Bed Management for Hospitals](/Opportunities/Intelligent_Bed_Management_for_Hospitals) — similar · Opportunities
- [Feedstock Blending Optimizer](/Opportunities/Feedstock_Blending_Optimizer) — similar · Opportunities
- [Supply Procurement Service](/Opportunities/Supply_Procurement_Service) — similar · Opportunities
- [Biologics Revenue Operations](/Opportunities/Biologics_Revenue_Operations) — similar · Opportunities
- [Autonomous Instrument Scheduling for Labs](/Opportunities/Autonomous_Instrument_Scheduling_for_Labs) — similar · Opportunities
- [Predictive EMT Fleet Routing](/Opportunities/Predictive_EMT_Fleet_Routing) — similar · Opportunities
- [Dynamic Compensation for Home Health](/Opportunities/Dynamic_Compensation_for_Home_Health) — similar · Opportunities
- [BrightDose Logic](/Opportunities/BrightDose_Logic) — similar · Opportunities
- [Semantic Vendor Resolution for Healthcare](/Opportunities/Semantic_Vendor_Resolution_for_Healthcare) — similar · Opportunities
- [Capacity Yield Engine](/Occupations/Personal_Care_and_Service_Occupations/Opportunities/Capacity_Yield_Engine) — similar · Opportunities
- [Narcotics Audit Automation](/Opportunities/Narcotics_Audit_Automation) — similar · Opportunities
- [Semantic Data Diffing for Healthcare](/Opportunities/Semantic_Data_Diffing_for_Healthcare) — similar · Opportunities
- [Retail Inventory Automation](/CompanyTypes/Supplement-Driven_Diet_Shops/Opportunities/Retail_Inventory_Automation) — similar · Opportunities
- [HPC Workload Optimization](/Opportunities/HPC_Workload_Optimization) — similar · Opportunities